2026年

1. Endo A, Enomoto Y*, Horiguchi R, Meguro S, Kawasaki H, Kosugi I, Iijima K, Takabayashi S, Baba S, Iwashita T. Pure Isolation, Culture, and Post-Injury Lineage Tracing of Mouse Visceral Pleural Mesothelial Cells. Am J Respir Cell Mol Biol. 2026 Jan 23:aanaf002. doi: 10.1093/ajrcmb/aanaf002.　プレスリリース

2025年

1. Kurita Y*, Meguro S, Sugiura Y, Togo S, Kouda Y, Kosugi I, Enomoto Y, Kawasaki H, Saitoh T, Suzuki M, Sakane J, Suzuki D, Ishidou O, Shinmura K, Iwashita T. Whole Slide Imaging-Free Supporting Tool for Cytotechnologists in Cervical Cytology. Mod Pathol. 2025;38(10):100817. doi: 10.1016/j.modpat.2025.100817.　プレスリリース
2. Ogata A, Enomoto Y*, Baba S, Tsuchida T, Kawashima M, Meguro S, Kawasaki H, Funai K, Iwashita T. Prevalence of subclinical pulmonary transthyretin amyloidosis in a pathology-based elderly cohort: the diagnostic value of routine amyloid staining. Respir Investig. 2025 Nov;63(6):1347-1351. doi: 10.1016/j.resinv.2025.10.017.
3. Miura K*, Iwashita T. Selective deletion or preservation of tissue components via enzymatic digestion monitored by scanning acoustic microscopy. Sci Rep. 2025 Aug 11;15(1):29300.
4. Utsunomiya A, Asano Y, Meguro S, Nagata Y, Nakano K, Kawasaki H, Kosugi I, Enomoto Y, Baba S, Iwashita T*. Autopsy Revealed an Extremely Rare Case of Hodgkin Lymphoma With Intranodal Extramedullary Hematopoiesis and Hemophagocytosis in a Patient With Severe Thrombocytopenia. Cureus. 2025 Feb 19;17(2):e79298. doi: 10.7759/cureus.79298.
5. Fukada A, Enomoto Y*, Horiguchi R, Aoshima Y, Meguro S, Kawasaki H, Kosugi I, Fujisawa T, Enomoto N, Inui N, Suda T, Iwashita T. Integrin α8 is a useful cell surface marker of alveolar lipofibroblasts. Respir Res. 2025 Jan 13;26(1):14. doi: 10.1186/s12931-025-03103-1.　プレスリリース

2024年

1. Meguro S*, Kawasaki H, Kosugi I, Enomoto Y, Osawa S, Sugimoto K, Baba S, Iwashita T. A Case of Brunner's Gland Hyperplasia Accompanied by an Increase in Endocrine Cells and Endocrine Cell Micronests. Cureus. 2024 Sep 5;16(9):e68688. doi: 10.7759/cureus.68688.
2. Kurita Y*, Meguro S, Kosugi I, Enomoto Y, Kawasaki H, Kano T, Saitoh T, Shinmura K, Iwashita T. Enhancing cervical cancer cytology screening via artificial intelligence innovation. Sci Rep. 2024 Aug 22;14(1):19535. doi: 10.1038/s41598-024-70670-6.
3. Ohishi A*, Enomoto Y*, Iwafuchi H, Meguro S, Kosugi I, Baba S, Iwashita T, Segawa Y, Ueno D, Iijima S. Autopsy case of linear nevus sebaceous syndrome with KRAS (G12D) mutation. Pathol Int. 2024 Sep;74(9):538-545. doi: 10.1111/pin.13463.
4. Asano Y, Utsunomiya A, Meguro S, Sano M, Inuzuka K, Takeuchi H, Kawasaki H, Kosugi I, Enomoto Y, Fujihiro M, Baba S, Iwashita T*. Development of an Undifferentiated Pleomorphic Sarcoma After Aortic Aneurysm Graft Replacement: A Case Report and Literature Review. Cureus. 2024 Jun 2;16(6):e61530. doi: 10.7759/cureus.61530.
5. Enomoto Y*, Arai Y, Meguro S, Kawasaki H, Kosugi I, Iwashita T. Goblet Cell Adenocarcinoma in the Stomach: A Case Report. Cureus. 2024 Apr 19;16(4):e58592. doi: 10.7759/cureus.58592.
6. Fujiuchi K, Aoki N, Ohtake T, Iwashita T, Kawasaki H*. Transitions in Immunoassay Leading to Next-Generation Lateral Flow Assays and Future Prospects. Biomedicines. 2024;12(10):2268. doi: 10.3390/biomedicines12102268.
7. Kawasaki H*, Hariyama T, Kosugi I, Meguro S, Iwata F, Shimizu K, Magata Y, Iwashita T. Human induced pluripotent stem cells are resistant to human cytomegalovirus infection primarily at the attachment level due to the reduced expression of cell-surface heparan sulfate. J Virol. 2024;98(3):e0127823. doi: 10.1128/jvi.01278-23.

2023年

1. Enomoto Y*, Katsura H, Fujimura T, Ogata A, Baba S, Yamaoka A, Kihara M, Abe T, Nishimura O, Kadota M, Hazama D, Tanaka Y, Maniwa Y, Nagano T, Morimoto M*. Autocrine TGF-β-positive feedback in profibrotic AT2-lineage cells plays a crucial role in non-inflammatory lung fibrogenesis. Nat Commun. 2023;14(1):4956. doi: 10.1038/s41467-023-40617-y.　プレスリリース
2. Suzuki D, Meguro S, Furusawa S, Hashimoto N, Kawasaki H, Kosugi I, Enomoto Y, Fujihiro M, Tsukui H, Iwashita T*. An autopsy case of disseminated carcinomatosis of the bone marrow from esophageal adenocarcinoma. Clin Case Rep. 2023;11(9):e7877. doi: 10.1002/ccr3.7877.
3. Fujimura T, Enomoto Y, Katsura H, Ogawa T, Baba S, Ogata A, Yamaoka A, Shiroguchi K, Morimoto M*. Identifying a Lung Stem Cell Subpopulation by Combining Single-Cell Morphometrics, Organoid Culture, and Transcriptomics. Stem Cells. 2023 Aug 16;41(8):809-820. doi: 10.1093/stmcls/sxad044.
4. Miura K*, Iwashita T. Observations of amyloid breakdown by proteases over time using scanning acoustic microscopy. Sci Rep. 2023 Nov 24;13(1):20642. doi: 10.1038/s41598-023-48033-4.
5. Kurita Y*, Meguro S, Tsuyama N, Kosugi I, Enomoto Y, Kawasaki H, Uemura T, Kimura M, Iwashita T. Accurate deep learning model using semi-supervised learning and Noisy Student for cervical cancer screening in low magnification images. PLoS One. 2023 May 18;18(5):e0285996. doi: 10.1371/journal.pone.0285996.　プレスリリース
6. Yamada S, Itoh T, Ikegami T, Imai A, Mochizuki D, Nakanishi H, Ishikawa R, Kita J, Nakamura Y, Takizawa Y, Okamura J, Noda Y, Iwashita T, Hariyama T, Suzuki M, Misawa K, Kawasaki H*. Association between human papillomavirus particle production and the severity of recurrent respiratory papillomatosis. Sci Rep. 2023;13(1):5514. doi: 10.1038/s41598-023-32486-8.
7. Itoh T, Yamada S, Ohta I, Meguro S, Kosugi I, Iwashita T, Itoh H, Kanayama N, Okudela K, Sugimura H, Misawa K, Hariyama T, Kawasaki H*. Identifying Active Progeny Virus Particles in Formalin-Fixed, Paraffin-Embedded Sections Using Correlative Light and Scanning Electron Microscopy. Lab Invest. 2023 Jan;103(1):100020. doi: 10.1016/j.labinv.2022.100020.

2022年

1. Suzuki D, Meguro S, Inagaki K, Hashimoto M, Kawasaki H, Kosugi I, Enomoto Y, Sugiyama M, Fukushima M, Iwashita T*. An autopsy case of ovarian mucinous cystic tumor complicated by ovarian abscess and a review of the English literature. Clin Case Rep. 2022 Nov 16;10(11):e6507. doi: 10.1002/ccr3.6507.
2. Koda K, Enomoto Y*, Aoshima Y, Amano Y, Kato S, Hasegawa H, Matsui T, Yokomura K, Mochizuki E, Matsuura S, Koshimizu N, Morita M, Kojima S, Watanabe A, Oyama Y, Ikeda M, Kusagaya H, Uto T, Sato J, Imokawa S, Kono M, Hashimoto D, Kamiya Y, Toyoshima M, Asada K, Morita M, Mikamo M, Yasui H, Hozumi H, Karayama M, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Suda T. Chemotherapy for patients with advanced lung cancer with interstitial lung disease: a prospective observational study. Ther Adv Chronic Dis. 2022 Jun 28;13:20406223221108395. doi: 10.1177/20406223221108395.

2021年

1. Aoshima Y, Enomoto Y*, Fukada A, Kurita Y, Matsushima S, Meguro S, Kosugi I, Kawasaki H, Katsura H, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Suda T, Iwashita T. Metformin reduces pleural fibroelastosis by inhibition of extracellular matrix production induced by CD90-positive myofibroblasts. Am J Transl Res. 2021;13(11):12318-12337.
2. Yagi H, Nakaguro M, Ito M, Okumura Y, Takahashi S, Aoshima Y, Enomoto Y, Meguro S, Kawasaki H, Kosugi I, Shimoyama Y, Ogawa H, Tateyama H, Iwashita T*. Difference in the distribution of tumor-infiltrating CD8+ T cells and FOXP3+ T cells between micronodular thymoma with lymphoid stroma and micronodular thymic carcinoma with lymphoid stroma. Pathol Int. 2021 Jul;71(7):453-462. doi: 10.1111/pin.13099.
3. Aoshima Y, Enomoto Y*, Muto S, Meguro S, Kawasaki H, Kosugi I, Fujisawa T, Enomoto N, Inui N, Nakamura Y, Suda T, Iwashita T. Gremlin-1 for the Differential Diagnosis of Idiopathic Pulmonary Fibrosis Versus Other Interstitial Lung Diseases: A Clinical and Pathophysiological Analysis. Lung. 2021 Jun;199(3):289-298. doi: 10.1007/s00408-021-00440-y.
4. Ooishi M, Yamada S, Itoh T, Meguro S, Yagi H, Kosugi I, Iwashita T, Shinmura K, Misawa K, Hariyama T, Kawasaki H*. Diagnosis of Ion-Exchange Resin Depositions in Paraffin Sections Using Corrective Light and Electron Microscopy-NanoSuit Method. Diagnostics (Basel). 2021;11(7):1193. doi: 10.3390/diagnostics11071193.
5. Kosugi I*, Arai Y, Baba S, Kawasaki H, Iwashita T, Tsutsui Y. Prolonged activation of cytomegalovirus early gene e1-promoter exclusively in neurons during infection of the developing cerebrum. Acta Neuropathol Commun. 2021 Mar 9;9(1):39. doi: 10.1186/s40478-021-01139-0.

2020年

1. Matsushima S, Aoshima Y, Akamatsu T, Enomoto Y, Meguro S, Kosugi I, Kawasaki H, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Funai K, Suda T, Iwashita T*. CD248 and integrin alpha-8 are candidate markers for differentiating lung fibroblast subtypes. BMC Pulm Med. 2020;20(1):21. doi: 10.1186/s12890-020-1054-9.
2. Suzuki D, Meguro S, Watanabe Y, Kawai T, Kyokane T, Aoshima Y, Enomoto Y, Kawasaki H, Yagi H, Kosugi I, Fukushima M, Baba S, Iwashita T*. Incidentally discovered mesenteric paraganglia as large as a lymph node in the sigmoid mesocolon, a possible origin of mesenteric paraganglioma. Pathol Int. 2020 Jul;70(7):476-478. doi: 10.1111/pin.12939.
3. Kawasaki H*, Itoh T, Takaku Y, Suzuki H, Kosugi I, Meguro S, Iwashita T, Hariyama T. The NanoSuit method: a novel histological approach for examining paraffin sections in a nondestructive manner by correlative light and electron microscopy. Lab Invest. 2020 Jan;100(1):161-173. doi: 10.1038/s41374-019-0309-7.

2019年

1. Meguro S*, Kusama Y, Matsushima S, Yagi H, Kawasaki H, Kosugi I, Tsuchida T, Baba S, Enomoto Y, Hosokawa S, Iwashita T. Nasal glomus tumor: A rare nasal tumor with diffuse and strongly positive synaptophysin expression. Pathol Int. 2019 Nov;69(11):672-674. doi: 10.1111/pin.12866.
2. Meguro S*, Matsushima S, Enomoto Y, Kawasaki H, Kosugi I, Tsuchida T, Baba S, Fukamizu H, Yamato Y, Iwashita T. Immunohistochemical examination using the pericyte marker myosin 1B in a perivascular myoid tumor of soft tissue with definitive pericytic differentiation. Pathol Int. 2019 Apr;69(4):246-248. doi: 10.1111/pin.12777.

2018年

1. Enomoto Y*, Matsushima S, Shibata K, Aoshima Y, Yagi H, Meguro S, Kawasaki H, Kosugi I, Fujisawa T, Enomoto N, Inui N, Nakamura Y, Suda T, Iwashita T. LTBP2 is secreted from lung myofibroblasts and is a potential biomarker for idiopathic pulmonary fibrosis. Clin Sci (Lond). 2018 Jul 31;132(14):1565-1580. doi: 10.1042/CS20180435.
2. Enomoto Y*, Matsushima S, Meguro S, Kawasaki H, Kosugi I, Fujisawa T, Enomoto N, Inui N, Nakamura Y, Suda T, Iwashita T. Podoplanin-positive myofibroblasts: a pathological hallmark of pleuroparenchymal fibroelastosis. Histopathology. 2018 Jun;72(7):1209-1215. doi: 10.1111/his.13494.
3. Murakami G*, Edamura M, Furukawa T, Kawasaki H, Kosugi I, Fukuda A, Iwashita T, Nakahara D. MHC class I in dopaminergic neurons suppresses relapse to reward seeking. Sci Adv. 2018 Mar 14;4(3):eaap7388. doi: 10.1126/sciadv.aap7388.
4. Meguro S*, Yamazaki S, Matsushima S, Kawata K, Kawasaki H, Tsuchida T, Kosugi I, Kobayashi Y, Baba S, Iwashita T. A case of a primary hepatic so-called adenosarcoma with heterotopic ossification: possibly of biliary adenofibroma origin. Hum Pathol. 2018 Mar:73:108-113. doi: 10.1016/j.humpath.2017.10.009.

2017年

1. Meguro S*, Akamatsu T, Matsushima S, Kosugi I, Kawasaki H, Arai Y, Baba S, Tsuchida T, Shido Y, Suda T, Iwashita T. Phenotypic characterization of perivascular myoid cell neoplasms, using myosin 1B, a newly identified human pericyte marker. Hum Pathol. 2017:62:187-198. doi: 10.1016/j.humpath.2016.12.024.
2. Kawasaki H*, Kosugi I, Meguro S, Iwashita T. Pathogenesis of developmental anomalies of the central nervous system induced by congenital cytomegalovirus infection. Pathol Int. 2017 Feb;67(2):72-82. doi: 10.1111/pin.12502.
3. Enomoto Y*, Nakamura Y*, Satake Y, Sumikawa H, Johkoh T, Colby TV, Yasui H, Hozumi H, Karayama M, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Inui N, Iwashita T, Kuroishi S, Yokomura K, Koshimizu N, Toyoshima M, Imokawa S, Yamada T, Shirai T, Hayakawa H, Suda T. Clinical diagnosis of idiopathic pleuroparenchymal fibroelastosis: A retrospective multicenter study. Respir Med. 2017 Dec;133:1-5. doi: 10.1016/j.rmed.2017.11.003.
4. Enomoto Y*, Nakamura Y, Colby TV, Johkoh T, Sumikawa H, Nishimoto K, Yoshimura K, Matsushima S, Oyama Y, Hozumi H, Kono M, Fujisawa T, Enomoto N, Inui N, Iwashita T, Suda T. Radiologic pleuroparenchymal fibroelastosis-like lesion in connective tissue disease-related interstitial lung disease. PLoS One. 2017 Jun 30;12(6):e0180283. doi: 10.1371/journal.pone.0180283.
5. Enomoto Y*, Nakamura Y, Enomoto N, Fujisawa T, Inui N, Suda T*. Japanese herbal medicine-induced pneumonitis: A review of 73 patients. Respir Investig. 2017 Mar;55(2):138-144. doi: 10.1016/j.resinv.2016.11.007.
6. Enomoto Y*, Suzuki Y*, Hozumi H, Mori K, Kono M, Karayama M, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Suzuki D, Ogawa N, Nakashima R, Mimori T, Iwashita T, Suda T. Clinical significance of soluble CD163 in polymyositis-related or dermatomyositis-related interstitial lung disease. Arthritis Res Ther. 2017 Jan 19;19(1):9. doi: 10.1186/s13075-016-1214-8.
7. Pirfenidone for primary Sjögren's syndrome-related fibrotic interstitial pneumonia. Enomoto Y*, Nakamura Y, Colby TV, Inui N, Suda T. Sarcoidosis Vasc Diffuse Lung Dis. 2017;34(1):91-96. doi: 10.36141/svdld.v34i1.5091.
8. Enomoto Y*, Yokomura K, Hasegawa H, Ozawa Y, Matsui T, Suda T. Healthcare-associated pneumonia with positive respiratory methicillin-resistant Staphylococcus aureus culture: Predictors of the true pathogenicity. Geriatr Gerontol Int. 2017 Mar;17(3):456-462. doi: 10.1111/ggi.12739.

2016年

1. Kawasaki H*, Kosugi I, Sakao-Suzuki M, Meguro S, Tsutsui Y, Iwashita T. Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain. J Vis Exp. 2016 Jul 24:(113):54164. doi: 10.3791/54164.
2. Enomoto Y*, Inui N, Yoshimura K, Nishimoto K, Mori K, Kono M, Fujisawa T, Enomoto N, Nakamura Y, Iwashita T, Suda T. Lung cancer development in patients with connective tissue disease-related interstitial lung disease: A retrospective observational study. Medicine (Baltimore). 2016 Dec;95(50):e5716. doi: 10.1097/MD.0000000000005716.
3. Enomoto Y*, Inui N, Kato T, Baba T, Karayama M, Nakamura Y, Ogura T, Suda T. Low forced vital capacity predicts cytotoxic chemotherapy-associated acute exacerbation of interstitial lung disease in patients with lung cancer. Lung Cancer. 2016 Jun;96:63-7. doi: 10.1016/j.lungcan.2016.03.017.

2015年

1. Kawasaki H*, Kosugi I, Sakao-Suzuki M, Meguro S, Arai Y, Tsutsui Y, Iwashita T. Cytomegalovirus initiates infection selectively from high-level β1 integrin-expressing cells in the brain. Am J Pathol. 2015 May;185(5):1304-23. doi: 10.1016/j.ajpath.2015.01.032.
2. Enomoto Y*, Inui N, Imokawa S, Karayama M, Hasegawa H, Ozawa Y, Matsui T, Yokomura K, Suda T. Safety of topotecan monotherapy for relapsed small cell lung cancer patients with pre-existing interstitial lung disease. Cancer Chemother Pharmacol. 2015 Sep;76(3):499-505. doi: 10.1007/s00280-015-2816-6.
3. Enomoto Y*, Kenmotsu H, Watanabe N, Baba T, Murakami H, Yoh K, Ogura T, Takahashi T, Goto K, Kato T*. Efficacy and Safety of Combined Carboplatin, Paclitaxel, and Bevacizumab for Patients with Advanced Non-squamous Non-small Cell Lung Cancer with Pre-existing Interstitial Lung Disease: A Retrospective Multi-institutional Study. Anticancer Res. 2015 Jul;35(7):4259-63.
4. Enomoto Y*, Oba M, Ishii N, Nakanaga K, Yagi Y, Hasegawa H, Ozawa Y, Matsui T, Yokomura K, Suda T. Rhinosinusitis and disseminated cutaneous infection caused by Mycobacterium chelonae in an immunocompromised patient. J Infect Chemother. 2015 Sep;21(9):691-4. doi: 10.1016/j.jiac.2015.04.014.
5. Enomoto Y*, Yokomura K, Suda T. Bilateral pleural effusion associated with miliary sarcoidosis. Am J Respir Crit Care Med. 2015 Feb 15;191(4):474-5. doi: 10.1164/rccm.201411-2022IM.

2014年以前　主な業績のみ抜粋

• Aberrant fetal macrophage/microglial reactions to cytomegalovirus infection. Ann Clin Transl Neurol. 2014, 1:570-588
• Direct isolation of myofibroblasts and fibroblasts from bleomycin-injured lungs reveals their functional similarities and differences. Fibrogenesis Tissue Repair. 2013; 6: 15.
• Effects of intrapulmonary viral tropism and cytokine expression on the histological patterns of cytomegalovirus pneumonia. Pathol Int. 2012; 62: 628-639.
• Mouse embryonic stem cells inhibit murine cytomegalovirus infection through a multi-step process. PLoS One. 2011; 6: e17492.
• Peripheral pulmonary papillary/glandular neoplasms with ciliated cells and a component of well-deifferentiated adenocarcinoma: report of three tumours. Histopathology 2010; 56: 265-269.
• Bmi-1 over-expression in neural stem/progenitor cells increases proliferation and neurogenesis in culture but has little effect on these functions in vivo. Dev Biol. 2009; 328: 257-72.
• Induction of cytomegalovirus-infected labyrinthitis in newborn mice by lipopolysaccharide: a model for hearing loss in congenital CMV infection. Lab Invest. 2008; 88: 722-730.
• Congenital anaplastic astrocytoma differentiated into pilocytic astrocytoma: an autopsy case. Neuropathology 2008; 28: 433-439.
• Enhancement of susceptibility of adult mouse brain to cytomegalovirus infection by infusion of epidermal growth factor. J Neurosci Res. 2007; 85: 2981-90.
• Cyclosporine inhibits mouse cytomegalovirus infection via a cyclophilin-dependent pathway specifically in neural stem/progenitor cells. J Virol. 2007; 81: 9013-23.
• Autopsy case of neuro-Behcet's disaese with multifocal neutrophilic perivascular inflammation. Neuropathology 2006; 26: 579-585.
• Differential expression of the immediate-early 2 and 3 proteins in developing mouse brains infected with murine cytomegalovirus. Arch Virol. 2006; 151: 2181-96.
• Differential expression of SLAM family members distinguishes stem and progenitor cells in the hematopoietic system and reveals endothelial niches for stem cells. Cell 2005; 121: 1109-1121.
• Cytomegalovirus infection inhibits the expression of N-methyl-D-aspartate receptors in the developing mouse hippocampus and primary neuronal cultures. Acta Neuropathol. 2005; 109: 475-482.
• Spatial differences in hematopoiesis but not in stem cells indicate a lack of regional patterning in definitive hematopoietic stem cells. Dev Biol. 2005; 283: 29-39.
• Bmi-1 dependence distinguishes stem cell self-renewal from restricted progenitor proliferation. Nature 2003; 425: 962-967.
• Hirschsprung disease is linked to defects in neural crest stem cell function. Science 2003; 301: 972-976.
• Neuron-specific activation of murine cytomegalovirus early gene e1 promotor in transgenic mice. Am J Pathol. 2003; 163: 643-6521.
• Temporally distinct requirements for endothelin receptor B in the generation and migration of gut neural crest stem cells. Neuron 2003; 40: 917-929.
• Identification of human SEP1 as a glial cell line-derived neurotrophic factor-inducible protein and its expression in the nervous system. Neuroscience 2003; 121: 899-906.
• Repair by Src kinase of function-impaired RET with multiple endocrine neoplasia type 2A mutation with substitutions of tyrosines in the COOH-terminal kinase domain for phenylalanine. Cancer Res. 2002; 62: 2414-22.
• Neural crest stem cells persist in the adult gut but undergo changes in self-renewal, neuronal subtype potential, and factor responsiveness. Neuron 2002; 35: 657-669.
• Innate immune responses to cytomegalovirus infection in the developing mouse brain and their evasion by virus- infected neurons. Am J Pathol. 2002; 161: 919-928.
• Expression of glial cell line-derived neurotrophic factor correlates with perineural invasion of bile duct carcinoma. Cancer 2002; 94: 167-74.
• The amount of immature glial cells in organotypic brain slices determines the susceptibility to murine cytomegalovirus infection. Lab Invest. 2002; 82: 1347-58.
• Reactivation of latent cytomegalovirus infection in mouse brain cells detected after transfer to brain slice cultures. J Virol. 2002; 76: 7247-54.